SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

PharmaCyte Biotech Inc. (PMCB)

PMCB RSS Feed
Add PMCB Price Alert      Hide Sticky   Hide Intro
Moderator: mick, Peacefulwendy, $Pistol Pete$, thenewmixer, fraum, concordia
Search This Board: 
Last Post: 11/20/2017 1:01:36 AM - Followers: 779 - Board type: Free - Posts Today: 1

Welcome to PharmaCyte BioTech
An OTCQB Company

PharmaCyte is a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box." This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed. For cancer, the therapy involves encapsulating genetically engineered human cells that convert the prodrug ifosfamide from its inactive form to its "cancer" killing form. These encapsulated live cells are implanted in a patient as close to the tumor as possible. Then ifosfamide is given IV at one-third the normal dose. When the ifosfamide comes in contact with the encapsulated live cells, they act as an artificial liver (where ifosfamide is normally activated) and activate the ifosfamide at the source of the cancer. For diabetes, PharmaCyte is developing a treatment for Type 1 diabetes and insulin-dependent Type 2 diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology. Once the encapsulated cells are implanted in a diabetic patient they will function as a "bio-artificial pancreas" for purposes of insulin production.






 


 





FDA Grants Orphan Drug Designation to Pharmacyte Biotech for Pancreatic Cancer Treatment



European Medicines Agency (EMA), the European Commission has granted the Orphan Drug designation to PharmaCyte’s subsidiary,
PharmaCyte Biotech Europe Limited, for PharmaCyte’s pancreatic cancer treatment

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2009/11/human_orphan_000395.jsp&mid=WC0b01ac058001d12b

 Company Address
   
PharmaCyte Biotech, Inc.

23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92652
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com
http://pharmacyte.com/
 

Market Value:
$122,386,272 a/o Dec 19, 2016

Shares Outstanding:
848,904,665 a/o Aug 29, 2016

Authorized Shares:
1,490,000,000 a/o Aug 26, 2014

Float:
817,204,665 a/o Aug 29, 2016


For more updated information please visit: 


http://www.otcmarkets.com/stock/PMCB/profile


Transfer Agent:
Signature  Stock Transfer Inc. Plano TX  Ph # 972-612-4120

Investor Relations


Stonegate Capital Inc.
8201 Preston Road
Suite 325
Dallas, TX 75225
United States

 

   All News Releases: 

http://www.pharmacytebiotech.com/news/

 


What is Cell-in-a-Box®?

The Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, storeand transport living cells. The proprietary technology can be used for a variety of purposes.
In healthcare, it facilitates the safe implantation of cells, holding them isolated from the immune system and allowing long term production of therapeutic molecules in patients. 
In biotechnology, the Cell-in-a-Box® technology protects cells in bioreactors and fermenters, while at the same time simplifying purification of bioproducts produced from the cells and reducing production cost. 
The technology can also be applied to probiotics, cosmetics and agriculture, environmental protection and monitoring, as well as forming the basis of a powerful research tool. 
The company’s proprietary cell packaging material, Gel8, used for the Cell-in-a-Box® technology, is derived from a naturally occurring material and is thus harmless to the environment, biologically inert and has been shown to be safe in humans.


http://austrianova.com/products/ 



Management Team:

Kenneth L. Waggoner, Chief Executive Officer and President
 

Gerald W. Crabtree, Ph.D. – Chief Operating Officer and Director


Carlos A. Trujillo – Chief Financial Officer and Director


Walter H. Gunzburg – Chief Scientific Officer


Dr. Matthias Lohr as Chairman of Scientific Advisory Board


Thomas Liquard - Chairman of the Audit Committe

  Dr. Eva Maria (Lilli) Brandtner – Director of Diabetes Program Development

Dr. Manuel Hidalgo, Scientific Advisory Board

 


 

 

 


***DISCLAIMER***
-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.





 
 


                                   

 
 
SureTrader
Interactive Brokers Advertisement
PMCB
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PMCB News: Current Report Filing (8-k) 10/10/2017 08:31:01 AM
PMCB News: Notice of Effectiveness (effect) 09/29/2017 06:01:57 AM
PMCB News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 09/28/2017 04:18:18 PM
PMCB News: Securities Registration Statement (simplified Form) (s-3) 09/13/2017 09:26:54 AM
PMCB News: Quarterly Report (10-q) 09/13/2017 06:06:08 AM
PostSubject
#78282  Sticky Note The letter is dated September 19, 2017, and $Pistol Pete$ 11/10/17 05:01:51 PM
#62231  Sticky Note in full/ #2/ 01-28-2017/ Keeping an Eye on mick 01/28/17 07:35:33 PM
#52881  Sticky Note Here is a very nice list of accomplishments... Peacefulwendy 09/28/16 11:17:44 AM
#78502   Good post. Ought to be a sticky so frosr6 11/20/17 01:01:36 AM
#78501   Its so obvious yet some still don't get concordia 11/19/17 08:08:51 PM
#78500   What I don’t understand is why they and bearspread 11/19/17 12:49:20 PM
#78499   Everyone needs to read post 78418. This is oldmusky 11/18/17 08:04:16 PM
#78498   Nope...wrong...look at the names associated with this stock...read efood125 11/17/17 07:49:50 PM
#78497   As a reminder. PMCB is a stock selling concordia 11/17/17 07:21:52 PM
#78496   Nice green close Go $PMCB $Pistol Pete$ 11/17/17 06:15:27 PM
#78495   Up from where? It still hasn't touched .044 again. takeyouhigher 11/17/17 05:54:01 PM
#78494   Having seen the FB post in OCT and tjclark0551 11/17/17 04:41:40 PM
#78490   Certainly happy with the stock this week. Would Pmcbinv 11/17/17 10:59:54 AM
#78489   i'm kinda feeling news on monday. maybe tulla236a 11/17/17 09:45:02 AM
#78488   $PMCB Pancreatic Cancer Market to Perceive Momentous Accruals $Pistol Pete$ 11/16/17 09:54:16 PM
#78487   You know that you own WAY to many DrJay522 11/16/17 06:31:28 PM
#78486   I think I understand your position. Perhaps mine Syzygenic 11/16/17 04:38:33 PM
#78485   Spikes are short lived, otherwise they'd be trends. Syzygenic 11/16/17 04:18:46 PM
#78484   There's nothing artificial about a stock having a Syzygenic 11/16/17 04:13:24 PM
#78483   Thanks, I appreciate your response! tjclark0551 11/16/17 04:12:21 PM
#78481   Yep $Pistol Pete$ 11/16/17 04:01:55 PM
#78480   Yeah right and we are up slowly and nicely $Pistol Pete$ 11/16/17 04:01:36 PM
#78479   That spike was short-lived. The half hour it takeyouhigher 11/16/17 02:49:20 PM
#78478   Better than 2 cents BioInvestor4 11/16/17 01:52:54 PM
#78477   WOW! .04 We're on a roll, aren't we? Stks_Not_Toys 11/16/17 01:49:06 PM
#78474   It’s artificial. Pmcb is a share selling scam frosr6 11/16/17 01:12:04 PM
#78473   It allows pmcb to rip off more people. frosr6 11/16/17 01:10:11 PM
#78472   Add to it...isn't there an mj etf coming efood125 11/16/17 12:13:50 PM
#78471   thanks! if this is causing the spike tulla236a 11/16/17 12:12:18 PM
#78470   Syzygenic, your scenario is interesting and maybe the iwitness4jc 11/16/17 12:09:11 PM
#78469   So this is what KW meant when he TRU STatus 11/16/17 11:45:23 AM
#78467   So what does it mean? It's pretty cut Syzygenic 11/16/17 11:17:21 AM
#78466   i agree. i looked up canadian stock tulla236a 11/16/17 10:49:46 AM
#78465   Pete, I guess the question to that move iwitness4jc 11/16/17 10:42:57 AM
#78464   $PMCB PharmaCyte recently applied to the BCSC to $Pistol Pete$ 11/16/17 10:30:09 AM
#78463   Nice $Pistol Pete$ 11/16/17 10:29:07 AM
#78462   Sure did, I posted it. I expect we'll Syzygenic 11/16/17 10:20:06 AM
#78461   Did you see the news today? $Pistol Pete$ 11/16/17 10:17:54 AM
#78460   somethings up? good volume and pps trend tulla236a 11/16/17 10:11:29 AM
#78459   I read that a different way. Heart skipped Uboat 11/16/17 09:37:25 AM
#78458   We're officially able to trade again in BC! Syzygenic 11/16/17 09:20:22 AM
#78456   No sir. You've misinterpreted my suggestion. The company Syzygenic 11/16/17 09:00:45 AM
#78455  Restored Pmcb is like building a house? Well frosr6 11/16/17 08:48:47 AM
#78454   Fair assessment of time frame, I believe. If Syzygenic 11/16/17 08:17:38 AM
#78453   I don't think there's any doubt people are Syzygenic 11/16/17 08:10:05 AM
#78452   PMCB is certainly not a biotech going bad, Syzygenic 11/16/17 06:45:13 AM
#78451   When Biotech’s go BAD. PMCB joining the list frosr6 11/16/17 05:52:02 AM
#78450   6/5/14 Boy how things change. Pmcb was mid frosr6 11/16/17 05:48:54 AM
#78449   Here’s another from 10k and he does call frosr6 11/16/17 05:40:17 AM
#78448   Your right he didn’t say p3 but did frosr6 11/16/17 05:31:54 AM
#78447   I think it was on Oct $Pistol Pete$ 11/15/17 09:36:39 PM
#78446   just read all of PMCBs prs and see thenewmixer 11/15/17 08:43:22 PM
#78445   No he never said that...but he did say efood125 11/15/17 08:27:03 PM
PostSubject